ddI, d4T, Hydroxyurea: new pancreatitis warning.
D019380:Anti-HIV Agents / Q000009:adverse effects*; D016049:Didanosine / Q000009:adverse effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects; D019384:Nucleic Acid Synthesis Inhibitors / Q000009:adverse effects; D010195:Pancreatitis / Q000139:chemically induced* / Q000150:complications; D018119:Stavudine / Q000009:adverse effects; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D019384:Nucleic Acid Synthesis Inhibitors; D018119:Stavudine; D016049:Didanosine; D006918:Hydroxyurea